Immunotherapy with monoclonal anti-idiotypic antibodies: Tumour reduction and lymphokine production
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 15 (4) , 215-222
- https://doi.org/10.1016/0145-2126(91)90123-b
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The role of cachectin/TNF in endotoxic shock and cachexiaImmunology Today, 1988
- The development of non-responsiveness to immunotherapy with monoclonal anti-idiotypic antibodies in a patient with B-CLLBritish Journal of Haematology, 1988
- Heterogeneous Responses of B-Cell Tumours to Anti-Ig and Anti-Idiotypic AntibodiesScandinavian Journal of Immunology, 1988
- Neopterin as a marker for activated cell-mediated immunity: Application in HIV infectionImmunology Today, 1988
- Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells.The Journal of Experimental Medicine, 1988
- Tumor necrosis factor and related cytotoxinsImmunology Today, 1987
- Response of resting human peripheral blood natural killer cells to interleukin 2.The Journal of Experimental Medicine, 1984
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.The Journal of Experimental Medicine, 1984
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982
- The nature of the immunoglobulin G on the surface of B lymphocytes in chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1981